Navigation Links
InfuSystem Holdings Appoints Two New Board Members
Date:4/28/2008

NEW YORK, April 28 /PRNewswire-FirstCall/ -- InfuSystem Holdings, Inc. (OTC Bulletin Board: INHI; INHIW; INHIU), the leading provider of ambulatory infusion pumps and associated clinical services, today announced the appointment of David C. Dreyer and James L. Freddo, M.D. to the board of directors, bringing the total to eight members.

Mr. Dreyer has served as chief financial officer, chief accounting officer and treasurer of AMN Healthcare Services, Inc. (NYSE: AHS) since September 2004. Prior to that, he served as chief financial officer and chief accounting officer of Sicor, Inc., a manufacturer of complex pharmaceuticals with operations in the United States, Italy, Mexico, Lithuania, China and Switzerland, which was acquired by Teva Pharmaceutical Limited. Prior to joining Sicor in 1997, Mr. Dreyer served in related senior financial positions within the pharmaceutical industry for companies such as Elan Corporation plc, Athena Neurosciences and Syntex. Mr. Dreyer holds a Bachelors Degree from Golden Gate University in San Francisco and is a certified public accountant in California.

Dr. Freddo has served as chief medical officer of Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) since July 2006. Prior to joining Anadys Pharmaceuticals, Dr. Freddo served as vice president, clinical site head and development site head at Pfizer Global Research and Development, La Jolla. From June 2002 until August 2005, Dr. Freddo served as executive director and site therapeutic area leader for oncology clinical developmen
'/>"/>

SOURCE InfuSystem Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Second Quarter Earnings Webcast
2. Agreement Executed for Amneal Pharmaceuticals to Acquire the Assets of Interpharm Holdings
3. Zimmer Holdings, Inc. Reports First Quarter Financial Results
4. NightHawk Radiology Holdings, Inc. to Host Conference Call to Discuss First Quarter 2008 Earnings Results
5. Lincare Holdings Inc. Announces First Quarter 2008 Financial Results
6. Zimmer Holdings to Present at Morgan Stanley Healthcare Unplugged Conference
7. HMS Holdings Corp. Hosts First Quarter 2008 Financial Teleconference and Presentation
8. PainCare Holdings Reports on Fiscal Year 2007 Results
9. LifeCare Holdings, Inc. Names McAlister Chairman and CEO
10. Duane Reade Holdings, Inc. Announces Resignation of Chief Marketing Officer
11. Eurosport Active World, Corp. Announces Reverse Merger Into Eagle International Holdings Group, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...itics see problems with the agency,s goals, commit...(HealthDay News) -- Responding to criticism that i...od supply, the U.S. Food and Drug Administration r...rotect consumers. , Among the most important ch... better relationships with state and local health ...
(Date:12/1/2008)...W ROCHELLE, N.Y., Dec. 1 Due to th...tion in the field of AIDS/HIV research and clinica...ll provide complimentary access to all archival on... the end of December in honor of World AIDS Day. F...Care and STDs ( www.liebertpub.com/apc ) and A...
(Date:12/1/2008)...PA, Calif., Dec. 1 Senet...es company engaged in the,development of technolo...nounced today that Dynamics Group AG, specialists ...tion management and research with offices in Zuric...t on the Company. , The Research Report, av...
(Date:12/1/2008)...nal December push wraps up successful disaster rel...wire-USNewswire/ -- The American Red Cross is aski...ms by raising $30 million in 30 days. This holiday...million goal for the Red Cross Campaign for Disast... $70 million since its launch in September, and th...
Breaking Medicine News(10 mins):Health News:FDA Touts Efforts to Enhance Food Safety 2Health News:FDA Touts Efforts to Enhance Food Safety 3Health News:FDA Touts Efforts to Enhance Food Safety 4Health News:Mary Ann Liebert, Inc. Provides Free Online Journal Access in Recognition of World AIDS Day 2Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 2Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 3
...city of life saving drugs as most companies have s...d Tax (VAT) system// implemented since April 1. 'T...e to confusion over the VAT', said Deepak Sinha, a...ents in a difficult situation as medicines for hea...
...arrested on suspicion of administering noxious sub...s working at the Addenbrooke's Hospital in Cambrid... to the patient. Hence she was arrested by the C...ber of medical staff but not a qualified nurse. Sh...
... No.19 continued for the second day with medicos d... the suspension of the Vice-Chancellor and the Reg... No 19, issued by the state government proposed to...-clinical PG medical seats to service candidates. ...
... to celebrate World Migratory Bird Day. Amid the A...ds, especially wild migratory ones are being// loo...s, and environmentalists will add to the gaiety of...edge of the Great Rift Valley. A worthy effort to ...
Other Medicine News:
(Date:11/25/2008)...ov. 25 Poniard,Pharmace...al company focused on,innovative oncology therapi...ategic alternatives for its preclinical research p...s resources on the clinical development of picopla...he initial commercialization of,picoplatin in the...
(Date:11/25/2008)...-FirstCall/ -- CardioVascular,BioTherapeutics, In...t it has,dosed the first patient in North America...l to treat patients with severe coronary heart dis...f CORonary heart Disease) trial will include,four...s in approximately 120,patients with severe coron...
(Date:11/24/2008)...ewswire-FirstCall/ -- Leaders of Schering-Plough C... for investors on the company,s research pipeline,... includes 46 new entities in clinical trials or un...s. , , "Research and development is adding ...inue our transformation," said Fred Hassan, chairm...
(Date:11/24/2008)... Unveils Rich Development Pipeline of Compounds Me...H, N.J., Nov. 24 Scherin... top-line results of a long-term Phase III clinica...M) (asenapine) demonstrating efficacy and safety i...ial, asenapine was statistically significantly mor...
Breaking Medicine Technology:Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention 2Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention 3Type 1 diabetes triggered by lazy regulatory T cells 3A McGill researchers 1903 1Type 1 diabetes triggered by lazy regulatory T cells 3A McGill researchers 1903 2Prominent Health Care Executive Kevin Kraushaar Joins Triadvocates LLC as Managing Principal of DC Office 9562 1Prominent Health Care Executive Kevin Kraushaar Joins Triadvocates LLC as Managing Principal of DC Office 9562 2Prominent Health Care Executive Kevin Kraushaar Joins Triadvocates LLC as Managing Principal of DC Office 9562 3Virginia Cares Uninsured Program 28VCUP 29 Announces Early Successes in Helping Uninsured Virginians Access Quality Healthcare 9559 1Virginia Cares Uninsured Program 28VCUP 29 Announces Early Successes in Helping Uninsured Virginians Access Quality Healthcare 9559 2Virginia Cares Uninsured Program 28VCUP 29 Announces Early Successes in Helping Uninsured Virginians Access Quality Healthcare 9559 3Health Options Inc s BlueMedicare HMO Earns NCQA Excellent Rating 9556 1Health Options Inc s BlueMedicare HMO Earns NCQA Excellent Rating 9556 2
...ER, Mass., Jun 27, 2007 (PrimeNewswire via COMTEX ... (Nasdaq:GNBT), the,leader in drug delivery for me...outh, announced today that it will be making three...f the European,Society of Pediatric Endocrinology ...t="_blank" href=,"http://www.espe2007.org/">www.es...
..., Ore.--(BUSINESS WIRE)--Jul 10, 2007 - AVI BioPha...artner Cook Medical has,completed target patient e...om a Phase II clinical trial known as Appraisal.,T...igned to study,the effect of the Neugene(R) antise...ith the placement of one or more bare metal,stents...
Other Medicine Technology:Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology 2Generex Biotechnology to Make Presentations At 46th Annual Meeting,of the European Society of Pediatric Endocrinology 3AVI BioPharma Partner Cook Medical Announces Completion of Patient,Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of,Cardiovascular Disease 2
...Lab's bring a new standard in the field of hammert...s. Made of medical grade silicone, these durable a... high level of flexibility while maintaining corre...le in varying stiffnesses. Lengths are determined ...
...7, VNS Therapy has been approved for use as an adj...res in adults and adolescents over 12 years of age...o antiepileptic medications. This indication is ba.... Efficacy, measured as median seizure reduction, ...
...Model CMU Cortical Mapping Unit offers you a conve... exposed cortex during surgery. To maximize the fi...d independently over the site. In addition, the cr...tions and each sterile, disposable electrode has i...
Introduction of the Selenia full field digital mammography system signals the beginning of a new era in the world of mammography. This masterpiece of elegance and innovation combines the latest advan
Medicine Products: